Study shows potential to revive abandoned cancer drug by nanoparticle drug delivery
Wednesday, May 2, 2012 - 13:30
in Health & Medicine
Current nanomedicine research has focused on the delivery of established and novel therapeutics. But a UNC team is taking a different approach. They developed nanoparticle carriers to successfully deliver therapeutic doses of a cancer drug that had previously failed clinical development due to pharmacologic challenges. They report their proof of principle findings in the April 30, 2012 early online edition of Proceedings of the National Academy of Sciences.